Ovintiv Inc. (OVV): what the price assumes
In the published model solve dated 2026-Q2, anchored at $57.89, Ovintiv Inc. (OVV) is priced for +10.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.
Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/OVV
Headline
| Field | Value |
|---|---|
| Ticker | OVV |
| Company | Ovintiv Inc. |
| Current price | $57.89/sh |
| Composition | Oil 40% / NGLs 24% / Natural gas 19% / Sales of purchased product 17% / Gathering and processing, and other 0% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin (value-band context) | 6.5% |
| Operating margin today | 9.7% |
| Margin compression (value-band) | -3.2pp |
| Implied growth | 10.8% |
| Multiple paid | 12x operating income |
The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.
Solve inputs: computed at a 11.2% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~5.5pp.
Reconcile: at the x-ray's 9.3% required return this reads ~0.2%/yr; the models below use their own rates.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | +0.46σ |
| cohort percentile (of 46 peers) | 41 |
| sustained it ~5 years at this level | 59% |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 5.51x | 5 | expensive |
| Earnings | 1.41x | 4 | expensive |
| Relative | 3.61x | 2 | expensive |
| Growth | 0.82x | 3 | justifies |
Families that justify the price: Growth Families that call it expensive: Asset, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.5%); the inversion above states its own rate.
Per-Model Detail (n=14)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $192.59 | 0.30x | yes | FCF base $2.3B, growth 7% (input: historical growth), terminal g 4.0%, WACC 7.5%, 5yr projection |
| DCF Exit Multiple | Growth | $70.58 | 0.82x | yes | Exit EV/EBITDA: 4.0x / 6.5x / 11.5x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | — | — | no | P/E 22x (blended: static sector reference 10x + trailing (TTM) 60x), scenarios: 16.5x / 22.0x / 26.4x (bear / base = reference held flat / bull), EV/EBITDA 6x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $10.51 | 5.51x | yes | BV/sh $41.74, ROE (TTM) 2.3%, ke 9.3% |
| Two-Stage Excess Return | Asset | $6.01 | 9.63x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $37.63 | 1.54x | yes | Rev $9.8B, growth 7% (input: historical growth; tapered), Terminal P/S: 1.2x / 1.6x / 2.0x (bear / base = today's held flat / bull, cap 6x) |
| Peter Lynch Fair Value | Relative | $10.59 | 5.47x | yes | EPS $0.88, growth 2% (input: historical EPS growth), PEG=29.77 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $80.93 | 0.72x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $2.81B × (1−15%) / WACC 7.5% → EPV (no growth) |
| Residual Income | Asset | $4.40 | 13.16x | yes | BV $41.74 + 5yr PV of (ROE (TTM) 2.3% − Kₑ 9.3%) × BV; BV grows 1.5%/yr |
| Graham Number | Asset | $28.79 | 2.01x | yes | √(22.5 × EPS $0.88 × BVPS $41.74) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | — | — | no | EBITDA $3.11B × sector EV/EBITDA 6.0x |
| FCF Yield | Earnings | $73.61 | 0.79x | yes | FCF $2266.0M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $28.48 | 2.03x | yes | EPS $0.88 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $29.87 | 1.94x | yes | BV $41.74 × (ROIC 5.4% / WACC 7.5%) |
| P/Sales Sector | Relative | — | — | no | Revenue $9.80B × sector P/S 1.2x |
| PEG Fair Value | Relative | $33.09 | 1.75x | yes | EPS $0.88 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $9.54 | 6.07x | yes | EPS $0.88 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Economic-Unit Decomposition (Sum Of The Parts)
One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.
| Unit | Role | Valuation basis | Revenue | Reported profit | Value evidence | Status |
|---|---|---|---|---|---|---|
| USA Operations | operating | enterprise | $5.9b | — | withheld | unresolved no unit value |
| Canadian Operations | operating | enterprise | $2.9b | — | withheld | unresolved no unit value |
| Market Optimization | operating | enterprise | $79.0m | — | withheld | unresolved no unit value |
No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.
Solvency
| Field | Value |
|---|---|
| Net debt | $3.1b |
| Net debt / NOPAT (after-tax) | 3.87x |
| Net debt / operating income (pre-tax) | 3.27x |
| Interest coverage | 2.4x |
| Share count CAGR (dilution) | 2.0% |
| Burning cash | no |
Bullet Takeaways
- The number that decides Ovintiv is free cash flow, not reported earnings. Q1 2026 generated $634 million of free cash flow even as the company booked a $630 million net loss on impairments. Cash is the real story; the loss is accounting.
- Priced on mid-cycle earnings, the stock is reasonable. At $52.39 the market pays about 14x normalized operating income, implying roughly 8% annual operating growth for five years, a rate within what Ovintiv has delivered.
- The transformation is the catalyst. The $3.0 billion Anadarko asset sale plus a note redemption cut net debt below $3.3 billion (under 0.8x EBITDA), and a new $3.0 billion buyback returns at least 75% of free cash flow to holders.
Bull Case
The single number that flips the verdict on Ovintiv is free cash flow, because for an oil and gas producer the reported earnings can lie while the cash does not. Q1 2026 makes the point starkly: the company posted a $630 million net loss, driven by impairments, yet generated $634 million of free cash flow in the same quarter (Ovintiv Q1 2026, stocktitan). The static valuation methods that anchor to book value and trailing GAAP earnings, which show a depressed return on equity near 1%, badly misread the business; the FCF-yield method, which capitalizes that $1.7 billion run-rate of cash, lands at $37 and the DCF methods reach the price. When you value Ovintiv on the cash it actually throws off, the picture is of a healthy producer, not a loss-maker.
The portfolio transformation is the structural change the price has not fully absorbed. Ovintiv sold its Anadarko assets for $3.0 billion and used the proceeds plus a $700 million note redemption to cut net debt below $3.3 billion by the end of April 2026, taking net debt to adjusted EBITDA below 0.8x (Ovintiv Q1 2026, stocktitan). The company is now focused on two of the best basins in North America: the oil-rich Permian (Q1 production 221 MBOE/d, 79% liquids) and the Montney (365 MBOE/d). Its filings note that quarterly revenue moves with benchmark prices, with Houston and WTI down 15% and 14% in the period (FY2025 10-K, accession 0001193125-26-064309), so a cleaner, lower-cost two-basin footprint at sub-0.8x leverage is built to generate cash across the price band.
The capital-return framework closes the loop and is the clearest catalyst. The board authorized a new $3.0 billion share repurchase program effective immediately and committed to returning at least 75% of full-year free cash flow through dividends and buybacks, alongside a $0.30 quarterly dividend (Ovintiv enhanced 2026 return framework, Globe and Mail). Against a peer cohort of Devon, EQT, Expand Energy, and Liberty, Ovintiv now carries one of the cleaner balance sheets, and Devon's own filing underscores the shared playbook: cash flow growth is the key tenet, pursued throughout commodity cycles (DVN FY2025 10-K, accession 0001193125-26-056485). Priced at about 14x mid-cycle operating income with a fortress balance sheet and 75% of free cash flow coming back, the bull case is a deleveraged producer returning cash at a reasonable multiple.
Bear Case
The price-to-fundamentals disconnect cuts the other way too, and the bear case starts there: the entire bull thesis depends on commodity prices the company does not control. The $630 million net loss and the impairments behind it were a direct consequence of lower benchmark prices, with Houston and WTI down 15% and 14% in the quarter. The mid-cycle earnings the valuation leans on are a normalized figure that assumes prices average through the cycle at levels that may not hold. If oil and gas settle into a lower band, the $634 million quarterly free cash flow that anchors the bull case compresses, the buyback shrinks, and the stock reprices on the lower cash generation. A producer is a leveraged bet on a price deck, and the price deck is the one variable nobody can forecast.
The asset-based methods are blunt about how little tangible support there is under the price. Simple Excess Return lands at $4.79, Two-Stage Excess Return at $2.54, and Residual Income at $1.81, all a fraction of the $52.39 price (June 27, 2026), because the trailing return on equity is near 1% and the business is currently earning well below its cost of capital on a GAAP basis. The reason only the growth-DCF reaches the price is that the price is a bet on mid-cycle economics that the current results do not show. That is a moat-and-durability premium for a commodity producer, which is exactly the kind of premium that evaporates fastest when sentiment on energy turns.
The operational and structural risks compound the commodity exposure. Ovintiv's plan requires $2.25 billion to $2.35 billion of annual capital just to hold production at 620 to 645 MBOE/d, so this is a treadmill business: a large share of cash flow must be reinvested simply to offset the steep decline rates of shale wells. The portfolio reshuffling, selling Anadarko, the prior NuVista-related activity, shows a company still actively reshaping itself, which carries integration and execution risk. There is also a measurement caveat worth flagging: the trailing operating-income figures from different sources diverge sharply here, so the exact multiple is sensitive to which basis you read. The bear case is the standard one for E&P: the cash looks great at today's strip, but the strip is the whole bet, and the asset value underneath offers almost no floor if prices fall.
Valuation
Ovintiv has to be valued on through-cycle economics, because its trailing GAAP results are distorted by impairments and a cyclical trough. The model recognizes this and prices the inversion on mid-cycle operating income: at $52.39 the market pays about 14x normalized operating income, implying roughly 8% annual operating growth for five years, computed at a 9.8% cost of capital with 4% terminal growth, where each point of cost of capital moves the implied growth about 5.8 points. On normalized earnings the priced-in assumption reads as within range.
The model dispersion is wide and needs interpreting. The growth and earnings-power methods that use normalized or cash figures cluster near or above the price (DCF Perpetual Growth $61, Earnings Power Value $73 on five-year average operating income, DCF Exit Multiple $50, FCF Yield $37), while the asset-based methods sit far below it (Simple Excess Return $4.79, Residual Income $1.81) because they read the trough-quarter return on equity. The honest read is that on mid-cycle cash generation Ovintiv is fairly-to-attractively priced, while on trailing trough earnings it looks expensive. The valuation is, at bottom, a bet on the commodity cycle: the methods that assume normalized prices support the stock, and the ones that read the trough do not. A measurement note: trailing operating income figures diverge materially across sources here, so treat the precise multiple as approximate.
Catalysts
Ovintiv reported Q1 2026 results on May 11, 2026, with $634 million of free cash flow and $1.2 billion of cash flow despite a $630 million net loss driven by impairments (Ovintiv Q1 2026, stocktitan). Montney production averaged 365 MBOE/d and Permian 221 MBOE/d (79% liquids), and full-year guidance was maintained at 205,000 to 212,000 barrels per day of oil and condensate on a $2.25 billion to $2.35 billion capital plan (Ovintiv Q1 2026 release, PR Newswire).
The forward setup is dominated by the balance-sheet transformation and the new return framework. The $3.0 billion Anadarko asset sale plus a $700 million note redemption cut net debt below $3.3 billion (under 0.8x EBITDA) by the end of April, and the board authorized a new $3.0 billion buyback while committing to return at least 75% of full-year free cash flow through dividends and buybacks, with a $0.30 quarterly dividend (Ovintiv enhanced 2026 return framework, Globe and Mail). The catalysts to watch are the oil and natural-gas price strip (the dominant driver), the pace of buyback execution against the $3.0 billion authorization, well productivity and capital efficiency in the Permian and Montney, and any further portfolio moves. The next quarterly print will show how much free cash flow the slimmed-down two-basin portfolio generates at the prevailing price deck.
Peer Cohorts (Per Segment, With Filing Citations)
USA Operations / Canadian Operations / Market Optimization (reported)
- DVN (DEVON ENERGY CORP/DE)
- FY2025 10-K: …Separately, the Railroad Commission of Texas has shown increasing regulatory focus on seismicity and the oil and gas industry in recent years, including by suspending all disposal well permits that inject into deep strata within the Northern Culberson-Reeves area due to increasing seismicity concerns. These or…
- FY2025 10-K: …of a portion of the estimates of proved oil and gas reserves. The company recorded depletion expense of $3.6 billion for the year ended December 31, 2025. We identified the estimate of proved oil and gas reserves used in the depletion of proved oil and gas properties as a critical audit matter. There was a high…
- OXY (OCCIDENTAL PETROLEUM CORPORATION)
- FY2025 10-K: 2023-12-31 0000797468 us-gaap:OperatingSegmentsMember us-gaap:ProductAndServiceOtherMember us-gaap:NonUsMember oxy:OilAndGasSegmentMember 2023-01-01 2023-12-31 0000797468 us-gaap:IntersegmentEliminationMember us-gaap:ProductAndServiceOtherMember oxy:OilAndGasSegmentMember 2023-01-01 2023-12-31 0000797468…
- FY2025 10-K: 797468 us-gaap:OperatingSegmentsMember us-gaap:ProductAndServiceOtherMember us-gaap:NonUsMember oxy:OilAndGasSegmentMember 2024-01-01 2024-12-31 0000797468 us-gaap:IntersegmentEliminationMember us-gaap:ProductAndServiceOtherMember oxy:OilAndGasSegmentMember 2024-01-01 2024-12-31 0000797468…
- EQT (EQT Corporation)
- FY2025 10-K: …The following sections present operating income and key operational measures for our three reportable segments of Upstream, Gathering and Transmission. We believe this information provides useful information to investors regarding our financial condition, results of operations and trends and uncertainties. See Note 2…
- FY2025 10-K: …when allocating capital and personnel to the Company's reportable segments. For the Company's Transmission segment, the CODM also reviews equity earnings recognized from, and the carrying value of, the Company's investment in the MVP Joint Venture. Substantially all of the Company's operating revenues and assets are…
- EOG (EOG RESOURCES, INC.)
- FY2025 10-K: …safe operations and robust environmental stewardship practices and performance, is integral in the implementation of EOG's strategy. With respect to information on EOG's working interest in wells or acreage, "net" oil and gas wells or acreage are determined by multiplying "gross" oil and gas wells or acreage by EOG's…
- FY2025 10-K: …for third party property damage, bodily injury or death claims resulting from an incident involving EOG's operations, including a sudden and accidental pollution event (subject to policy terms and conditions). EOG also maintains first party property damage insurance that covers damage to EOG's equipment, facilities…
- APA (APA Corporation)
- FY2025 10-K: …require the monitoring of seismic activity. While the Company remains focused on reusing or recycling water over disposal of water, the Company's costs for obtaining and disposing of water could increase significantly if reusing and recycling water becomes impractical. Further, compliance with reporting and…
- FY2025 10-K: …The interests may additionally be subject to obligations or duties under applicable laws, ordinances, rules, regulations, and orders of arbitral or governmental authorities. In addition, the interests may be subject to burdens such as production payments, net profits interests, liens incident to operating agreements…
- CHRD (Chord Energy Corp)
- FY2025 10-K: …harm with customers, regulators, lenders, investors or other stakeholders and increase litigation risks. Any material reduction in the capital available to the fossil fuel industry could make it more difficult to secure funding for exploration, development, production, transportation and processing activities, which…
- FY2025 10-K: …containment and cleanup of crude oil spills. The OPA applies to vessels, offshore facilities and onshore facilities, including E&P facilities that may affect WOTUS. Under the OPA, responsible parties including owners and operators of onshore facilities may be held strictly liable for crude oil cleanup costs and…
- AR (ANTERO RESOURCES CORPORATION)
- FY2025 10-K: …to attract considerable attention in the United States and in foreign countries. In the United States, no comprehensive climate legislation has been implemented at the federal level. Federal regulators, state and local governments, and private parties have taken (or announced that they plan to take) actions that have…
- FY2025 10-K: …and gas properties 15,275,163 14,845,708 Accumulated depletion ( 5,625,419 ) ( 5,674,702 ) Net capitalized costs (1) $ 9,649,744 9,171,006 (1) Net capitalized costs does not include $ 706 million related to the Utica Shale Properties held for sale as of December 31, 2025, including $ 28 million…
- CTRA (COTERRA ENERGY INC.)
- FY2025 10-K: …0000858470 ☒ FALSE 2025 FY FALSE P3Y http://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent…
- FY2025 10-K: …and transportation agreements, lease obligations, operational agreements, drilling and completion obligations, derivative obligations and asset retirement obligations. Other joint owners in the properties operated by us could incur a portion of these costs. We expect that our sources of capital will be adequate to…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.